NEA Management Company, LLC Long-Term Concentrated

CIK: 0001512848 · Show all filings

Period: Q4 2016 (← Previous) (Next →)

Filing Date: Feb 9, 2017

Total Value ($000): $2,514,984 (100.0% shares, 0.0% debt)

Holdings (39)

TESARO INC 54.9%
Value ($000) $1,381,797 Shares 10,275,113 Est. Cost $34.30 Unrealized
ARDX ARDELYX INC 8.0%
Value ($000) $199,987 Shares 14,083,582 Est. Cost $12.70 Unrealized +11.7%
DERMIRA INC 4.2%
Value ($000) $106,357 Shares 3,506,649 Est. Cost $15.35 Unrealized
EPIZYME INC 3.0%
Value ($000) $75,756 Shares 6,260,851 Est. Cost $24.91 Unrealized
SENSEONICS HOLDINGS INC 2.8%
Value ($000) $70,235 Shares 26,305,286 Est. Cost $2.86 Unrealized
ACHAOGEN INC 2.7%
Value ($000) $67,901 Shares 5,215,125 Est. Cost $4.67 Unrealized
GROUPON INC 2.7%
Value ($000) $66,652 Shares 20,075,762 Est. Cost $8.55 Unrealized
CRSP CRISPR THERAPEUTICS AG 2.6%
Value ($000) $65,252 Shares 3,220,728 Est. Cost $18.69 Unrealized 0.0%
RA PHARMACEUTICALS INC 2.1%
Value ($000) $53,068 Shares 3,493,636 Est. Cost $15.19 Unrealized
GLYCOMIMETICS INC 2.1%
Value ($000) $52,363 Shares 8,584,128 Est. Cost $16.33 Unrealized
CLOVIS ONCOLOGY INC 2.0%
Value ($000) $50,634 Shares 1,139,890 Est. Cost $66.98 Unrealized
PROTEOSTASIS THERAPEUTICS INC 1.7%
Value ($000) $43,606 Shares 3,556,778 Est. Cost $10.41 Unrealized
ADAPY ADAPTIMMUNE THERAPEUTICS PLC 1.6%
Value ($000) $40,018 Shares 9,880,999 Est. Cost $8.13 Unrealized
LXRX LEXICON PHARMACEUTICALS INC 1.3%
Value ($000) $32,947 Shares 2,382,286 Est. Cost $12.29 Unrealized +30.5%
CARE COM INC 1.1%
Value ($000) $27,947 Shares 3,260,989 Est. Cost $8.15 Unrealized
AEROHIVE NETWORKS INC 1.1%
Value ($000) $26,639 Shares 4,673,536 Est. Cost $8.02 Unrealized
NEVRO CORP 1.0%
Value ($000) $26,134 Shares 359,678 Est. Cost $38.67 Unrealized
TREVENA INC 0.9%
Value ($000) $22,413 Shares 3,811,691 Est. Cost $7.47 Unrealized
ENDOLOGIX INC 0.6%
Value ($000) $14,244 Shares 2,490,204 Est. Cost $8.36 Unrealized
TRACON PHARMACEUTICALS INC 0.5%
Value ($000) $13,520 Shares 2,759,217 Est. Cost $11.16 Unrealized
STRONGBRIDGE BIOPHARMA PLC 0.4%
Value ($000) $9,939 Shares 4,141,308 Est. Cost $5.09 Unrealized
AUPH AURINIA PHARMACEUTICALS INC 0.3%
Value ($000) $8,542 Shares 4,067,743 Est. Cost $3.43 Unrealized -6.1%
CASCADIAN THERAPEUTICS INC 0.3%
Value ($000) $7,722 Shares 1,791,666 Est. Cost $4.31 Unrealized
RIGEL PHARMACEUTICALS INC 0.3%
Value ($000) $7,719 Shares 3,243,150 Est. Cost $3.34 Unrealized
AVEO PHARMACEUTICALS INC 0.2%
Value ($000) $5,596 Shares 10,362,694 Est. Cost $0.96 Unrealized
MIRNA THERAPEUTICS INC 0.2%
Value ($000) $5,355 Shares 2,974,811 Est. Cost $6.25 Unrealized
DASAN ZHONE SOLUTIONS INC 0.2%
Value ($000) $4,704 Shares 4,781,290 Est. Cost $1.14 Unrealized
SUNESIS PHARMACEUTICALS INC 0.2%
Value ($000) $4,700 Shares 1,298,274 Est. Cost $4.37 Unrealized
ARCA BIOPHARMA INC 0.2%
Value ($000) $4,162 Shares 1,460,209 Est. Cost $4.96 Unrealized
CSBR CHAMPIONS ONCOLOGY INC 0.2%
Value ($000) $3,953 Shares 1,562,500 Est. Cost $6.08 Unrealized -68.0%
ROKA BIOSCIENCE INC 0.2%
Value ($000) $3,788 Shares 893,471 Est. Cost $4.24 Unrealized
AKARI THERAPEUTICS PLC 0.1%
Value ($000) $3,183 Shares 452,167 Est. Cost $13.49 Unrealized
ARQULE INC 0.1%
Value ($000) $3,176 Shares 2,520,316 Est. Cost $2.32 Unrealized
ZOSANO PHARMA CORP 0.1%
Value ($000) $1,601 Shares 2,052,809 Est. Cost $10.11 Unrealized
PARATEK PHARMACEUTICALS INC 0.0%
Value ($000) $1,020 Shares 66,245 Est. Cost $38.55 Unrealized
AGILE THERAPEUTICS INC 0.0%
Value ($000) $761 Shares 133,488 Est. Cost $6.70 Unrealized
OREXIGEN THERAPEUTICS INC 0.0%
Value ($000) $645 Shares 370,900 Est. Cost $3.32 Unrealized
CERECOR INC 0.0%
Value ($000) $524 Shares 595,435 Est. Cost $2.01 Unrealized
CATALYST BIOSCIENCES INC 0.0%
Value ($000) $424 Shares 652,380 Est. Cost $4.66 Unrealized